Provided by Tiger Fintech (Singapore) Pte. Ltd.

PAVmed

0.7700
-0.0201-2.54%
Post-market: 0.77000.00000.00%16:05 EDT
Volume:44.79K
Turnover:34.69K
Market Cap:13.16M
PE:1.55
High:0.7900
Open:0.7600
Low:0.7600
Close:0.7901
Loading ...

Lucid Diagnostics to sell 13.94M shares at $1.10 in registered direct offering

TIPRANKS
·
04 Mar

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

PR Newswire
·
04 Mar

BRIEF-Tasso Partners Reports 18.9% Passive Stake In PAVmed As Of Feb 21 - SEC Filing

Reuters
·
01 Mar

Renowned Investigators Awarded $8 Million Nih Grant to Study Lucid Diagnostics' Esoguard® in at-Risk Patients Without Symptomatic Gerd

THOMSON REUTERS
·
27 Feb

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

PR Newswire
·
27 Feb

Lucid Diagnostics Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
25 Feb

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire
·
25 Feb

PAVmed and Subsidiary Veris Health Complete Private Placement Financing

THOMSON REUTERS
·
24 Feb

Press Release: PAVmed and Subsidiary Veris Health Complete Private Placement Financing

Dow Jones
·
24 Feb

BRIEF-PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement

Reuters
·
18 Feb

PAVmed Regains Compliance With Nasdaq Listing Standards

MT Newswires Live
·
18 Feb

PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement

THOMSON REUTERS
·
18 Feb

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement

PR Newswire
·
18 Feb

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

PR Newswire
·
06 Feb

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

PR Newswire
·
13 Jan

Lucid Inks New Partnership With VITALExam: Stock to Gain?

Zacks
·
26 Dec 2024

Lucid Diagnostics Secures 180-Day Extension to Regain Compliance With Nasdaq Listing Rules

MT Newswires Live
·
24 Dec 2024

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

THOMSON REUTERS
·
23 Dec 2024

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

PR Newswire
·
23 Dec 2024

PAVmed files $125M mixed securities shelf

TIPRANKS
·
21 Dec 2024